A simple, reproducible, and rapid gas chromato graphic method for short-chain fatty acid determina tion in human feces was developed. It involves direct injection of fecal supernatants into the gas chromato graph, without any pretreatment. Contamination of the gas chromatographic column with nonvolatile fe cal material was prevented by the use of a glass liner in the injector. This liner, which acted as a precolumn, was stoppered with a glass wool plug at the lower end of the liner. Injection was performed against the glass wall of the liner, ensuring an immediate contact of the injected sample with the hot glass wall. More than 100 injections of fecal supernatants could be carried out before the liner had to be replaced by a new one. Peak tailing and ghosting was prevented by the use of for mic acid in the fecal samples. The method gave sharp peaks with baseline separation for all the fatty acids. Short-chain fatty acids (SCFA)2 are produced largely as a result of the breakdown of dietary carbohydrate in the gut by anaerobic bacterial fermentation (1). Acetic, propionic, and ¿7-butyric acid are quantitatively the most important ones. The SCFA present in minor amounts in the human colon (i-butyric, ^-valeric, i-valeric, and i3-caproic acid (2)) primarily originate from protein catabolism and in particular from degradation of certain amino acids (3).
techniques to measure fecal SCFA concentrations are rather cumbersome and time-consuming. Most proce dures involve some kind of pretreatment of the fecal samples followed by gas chromatography (GC). Feces have been pretreated by extraction in organic solvents (9-11), ultrafiltration (12, 13) , and derivatization (14, 15) , steam distillation (16) , and vacuum distillation (3, (17) (18) (19) . At present, the latter method of vacuum dis tillation followed by GC of the aqueous SCFA solutions is used most often. Although GC on capillary columns has been used more and more, GC on packed columns is still the method of choice for the separation of fecal SCFA. In addition to GC, high-performance liquid chro matography has also been applied to the analysis of fecal SCFA (13, 20) . A major drawback of the abovementioned methods is the time-consuming pretreat ment procedures, e.g., for the vacuum distillation tech nique about 45 min are required for one complete analysis, Moreover, losses of the more volatile acids may occur during pretreatment. No methods were found whereby direct injection of human fecal superna tants into the gas chromatograph was applied, without using any pretreatment.
In the present study we describe a very simple, repro ducible, and rapid method for fecal SCFA determina tion, involving direct injection of fecal supernatants into the gas chromatograph, without any pretreatment.
MATERIALS AND METHODS

Reagents
Formic acid, acetic acid (C2), propionic acid (C3), isobutyric acid (i-C4), n~butyric acid (C4), isovaleric acid (jf-C5), /2-valeric acid (C5), n-caproic acid (C6), and 2ethylbutyric acid (internal standard, IS), all analytical grade (> 97% purity) were obtained from Merck (Darmstadt, Germany). The column packing material, 10% SP-1200/1% H 3P O 4 on 80/100 Chromosorb W AW, came from Supelco (Bellefonte, PA). The glass wool (di~ methylchlorosilane treated) was from Chrompack (Middelburg, The Netherlands) and the small glass balls with a diameter of 1 mm were from Tamson (Zoetermeer, The Netherlands).
Preparation o f Fecal Homogenate
Fresh fecal material was frozen on dry ice immedi ately after collection and stored at -20°C until pro cessing. Homogenates were prepared by suspending 10 g of fecal material in 50 ml of distilled water, giving a 16% (w/v) fecal suspension. One milliliter of the homo geneous suspension was transferred into a conical poly propylene micro sample tube (Eppendorf, 1 ml) and centrifuged for 1 min at lO^OOOg'in an Eppendorf centri fuge. Ten microliters of a solution of 150 mmol/liter of 2-ethylbutyric acid (the gas chromatographic internal standard) in 100% formic acid was added to 100 pi of the supernatant in an Eppendorf tube (1 ml), resulting in a 9% formic acid suspension. This latter suspension was centrifuged for 1 min at 10,000gand 0,6-1.0 pi of the clear brownish supernatant was injected in the gas chromatograph for analysis. The final concentration of SCFA in the supernatant of the fecal homogenate (mmol/liter) must be multiplied by (5 + x) to obtain the concentration in the original feces in millimoles per kilogram wet weight and by (5 + a)/(1 -x) to calculate the SCFA concentration in millimoles per kilogram dry weight. In this equation, x represents the wet weight fraction of the feces. The wet weight fraction x was determined by freeze-drying 5 g of the fecal samples. Using this method for 40 fecal samples, we obtained an x o f 0.76 ± 0.05 (mean ± SD; range, 0.65-0.85),
Preparation of Fecal Supernatant
Fecal samples were homogenized with a blender and ultracentrifuged for 2 h at 4°C and 30,000^. No fluid was added to the fecal sample for this homogenization. The supernatant was carefully removed. This fecal su pernatant fraction was stored at -20°C until analysis. For gas chromatographic analysis, 100 pi of fecal super natant was processed in the same manner as described above for fecal homogenate resulting in a clear darkbrown supernatant of which 0 .6 -1 .0 pi was injected. The final concentration in the fecal supernatant (mmol/ liter) must be multiplied by the wet weight fraction x (about 0.75, see above) to obtain the concentration in the original feces in millimoles per kilogram wet weight and by (a/( 1-a)) to calculate the concentration in the original feces in millimoles per kilogram dry weight.
Gas Chromatography
The gas chromatograph used was a Chrompack Model CP 9001, equipped with a flame ionization detector and a CP-9010 automatic liquid sampler (Chrompack, Mid delburg, The Netherlands). The sample injection rate of the auto injector was 50 ¡ills. Data handling was carried out with the Maestro chromatography data system (Chrompack). The injection port of the chromatograph was installed with a hand-made glass liner (length: 8 cm; o.d. 6 mm; i.d. 3 mm) ( Fig. 1A) . This liner, which acted as a precolumn to prevent contamination of the chromatographic column with brown nonvolatile fecal material, was stoppered with a dimethylchlorosilanetreated glass wool plug. Injection was performed against the glass wall of the liner above the glass wool plug, by means of a 10-/zl Hamilton syringe with a slightly bent syringe needle, ensuring an immediate contact of the injected sample with the hot glass w all The results in this study were all obtained using the above-mentioned injection technique. During preparation of this article, a slight modification in injection technique was developed. For ensuring an immediate contact of the injected sam ple with hot glass, the liner was partly filled with small glass balls with a diameter of 1 mm. Injection was per formed by means of a I0~pl Hamilton syringe inside the liner between the glass balls, penetrating the glass balls by about 1 cm (Fig. IB) .
The conditions were as follows; Column, 2 m X 2 mm i.d., glass, packed with 10% SP 1200/1% H3P 0 4 on 80/ 100 Chromosorb W AW; column temperature, 145°C; injection port temperature, 200°C; detector tempera ture, 180°C. The carrier gas was N2, 20 ml/min; H2, 30 ml/min; air, 300 ml/min. Freshly packed columns were conditioned overnight at 190°C. A few l-pl injections of 10% formic acid were made to clear the column of unknown impurities. There was no need to regularly prime the column with formic acid or to add formic acid to the carrier gas.
Calibration and Recovery Studies
An aqueous stock standard (solution A) was prepared with a concentration of 250 mmol/liter for C2, 100 mmol/liter for C3 , and 50 mmol/liter for C4, i-C4j C5t i-Cs, and C6. This stock solution was diluted 2,5-, 5-, 10-, and 20-fold to obtain standard solutions B, C, D, and E, with concentrations ranging from 12.5 to 100 mmol/liter for C2, 5 to 40 mmol/liter for C3, and 2.5 to 20 mmol/liter for C4-C 6. To 100 pi of each standard solution 10 pi of a solution of 150 mmol/liter of 2-ethyl butyric acid (IS) in 100% formic acid was added. These standards were used for daily calibration. A linear rela tionship was found between the peak area ratio SCFA/ IS and concentration for each individual SCFA, The peak area responses in FID, although linear, differ for the different fatty acids. The peak areas relative to C4 for equimolar amounts of the various SCFA amounted to 0.19 ± 0.01 for C2l 0.49 ± 0.01 for C3, 1.00 ± 0.02 for i-C4l 0.94 ± 0.03 for both i-C5 and C5, and L01 ± 0.05 for C6 (mean values ± SD, n = 8).
Recovery studies were performed from fecal superna- tant and from feces, Feces was processed as described above for fecal homogenate. Known amounts of SCFA were added to one fecal supernatant and to one fecal sample. After vortexing, the mixtures were kept at room temperature for 15 min and the clear fecal supernatants were analyzed by direct injection. The intraassay reproducibility was determined for a standard SCFA solution and for a fecal supernatant by analyzing each sample eight times on the same day. For each gas chromatographic analysis, 100 pi of the sample was processed as described under preparation of fecal homogenate. The interassay reproducibility was determined by analyzing the same samples on 5 different days, during a 3-month period. In between, the samples were stored at -20°C.
Vacuum Distillation of Fecal Samples
The recoveries obtained with the direct injection method (see above) were compared with those obtained after vacuum distillation. For vacuum distillation of fecal samples, we adapted the procedure as described earlier for serum (21) . In short, to 3.0 ml of fecal super natant or fecal homogenate 0.3 ml of the IS solution (150 mmol/liter of 2-ethylbutyric acid in 100% formic acid) was added, resulting in a 9% formic acid solution (pH 2-2.5). After addition of one drop of 20% H3P 0 4, the mixture was vacuum distilled in an all-glass equip ment by means of a water suction pump. During this procedure, the sample was heated from room tempera ture to 70°C while the receiver tube was cooled in liquid nitrogen. Distillation was complete within 30 min. The clear colorless distillate was thawed and 0.6 -1 .0 pi was injected in the gas chromatograph for analysis.
Freeze-Drying of Fecal Samples
Five grams of feces was transferred into a glass vial of 15 ml. The feces was frozen by liquid nitrogen and freeze-dried for 2 days, using a Hetosicc freeze-dryer (type CD 52, Heto InterMed, Birkerod, Denmark). The dry weight fraction was determined by weighing of the freeze-dried samples. The freeze-dried feces was made up with isotonic saline to the original weight of the feces sample, fecal supernatant was prepared, and the SCFA concentrations in the fecal supernatant of four freeze-dried fecal samples were compared with those before freeze-drying. between the glass balls with a 10-pl Hamilton syringe, with the needle penetrating the glass balls by about 1 cm. This injection technique has two advantages. First, no differences were observed between automated and hand injection. The glass balls largely increased the glass surface in the injection area and gave an evenly distrib uted contamination of the glass balls and the liner's glass wall in the injection area, also during automated injec tion. Routinely, the liner was replaced after 100 injections of fecal samples. Second, this latter technique always ensures an immediate contact between sample and hot glass and always gave sharp resolved peaks, also in the case of a slowly performed injection as in Fig. 3B . The data presented here were all obtained using the first in jection technique, viz, injection by hand against the glass wall of an empty liner. However, the injection technique between glass balls gave exactly the same results. When comparing the concentrations of the various fatty acids obtained using injection between glass balls with those obtained with the first injection technique, excellent cor relations were seen (r = 0.9996-1.0000, n ~ 10, 5 stan dards and 5 fecal samples).
RESULTS
Gas Chromatographic Separation
Recovery and Precision
Recoveries of the individual SCFA from spiked sam ples of fecal supernatant ranged between 92 and 102% and of feces between 95 and 102% ( Table 1) . that the sample comes in immediate contact with the hot glass wall of the liner (Fig. 1A) . If not, broad unresolved peaks were obtained (Fig. 3B) 
, such as in the case of a slowly performed injection where immediately after injec tion the sample sticks at the end of the injection needle or after a normal injection with a straight needle where the sample was injected in the gas phase of the liner and not against the glass wall. This phenomenon was observed both for fecal samples and for the clear standard solutions. During injection of fecal samples, brown non volatile fecal material adheres onto the glass wall inside the liner in the injection area. This disturbs the gas chro matographic separation after more than about 100 injec tions by hand. This is first seen for the peak of Q which then broadens and begins to tail. If so, one must replace the glass liner by a new one, which can be done within 1 min. Using automated injection, tailing of the C2 peak was already observed after about 40 injections. During automated injection the sample was always injected in exactly the same way, thereby contaminating the wall of the glass liner at only one spot. The injection area became therefore sooner contaminated than when using injection by hand, the latter resulting in a more evenly distributed contamination.
An alternative injection technique is the use of a liner, partly filled with small glass balls with a diameter of 1 mm (Fig, IB) The intraassay and interassay reproducibility was excellent ( Table 2) 
, with very low variation coefficients. The interassay reproducibility was determined by ana lyzing the same samples on 5 different days, during a 3-month period. In between, the samples were stored at -20°C. The low interassay variation shows that samples can be stored at -20°C without any change in SCFA concentrations.
Once the samples have been prepared for GC injec tion, viz. after addition of the internal standard in for mic acid, they are quite stable. Storage for 6 months at 4 or -20°C and for 1 week at room temperature showed no change in SCFA concentrations.
The detection limit amounted to 0.1 mmol/liter for C2 and to 0.02-0.05 for C3-C 6, which is suitable for the analysis of fecal samples. 
Concentration of SCFA in Fecal Supernatant
The characteristics of the SCFA concentrations in human fecal supernatant are depicted in Table 3 . Ace tic acid, propionic acid, and /3-butyric acid are quantita tively the most important ones and constitute about 90% of intestinal SCFA in molar ratios of ca. 68:20:12.
Freeze-Dried Fecal Samples
Concentrations of SCFA after freeze-drying were compared with those before freeze-drying. Recoveries after freeze-drying were almost quantitative (mean ± SD, n = 4: C2, 101 ± 10; C3, 93 ± 7; i-C4t 90 ± 3; C4, 91 ± 7; /-C5, 91 ± 7; C5, 93 ± 9; C6, 101 ± 3), Almost no losses of SCFA were observed during freeze-drying of fecal samples. The pH as measured in 40 fecal supernatants amounted to 6.50 ± 0.24 (range 6.1 to 6.9). The pjKa of the SCFA (4) is approximately 4.8, Thus, at fecal pH the SCFA are in ionized nonvolatile form for more than 95%, explaining the almost quantitative recovery after freeze-drying. One might also make the samples alkaline before freeze-drying to prevent any loss of SCFA during lyophilization (15) .
Comparison of the Direct Injection Method with the Vacuum Distillation Method
The direct injection technique as described in this paper was compared with the most often used tech nique of vacuum distillation, for three samples, one fecal supernatant, a fecal homogenate 1 , and a fecal homogenate 2, the latter spiked with stock solution A (2 vol of fecal homogenate and 1 vol of solution A). The absolute peak areas before and after vacuum distilla tion were compared, to assess potential losses of SCFA during vacuum distillation. The thus obtained absolute recoveries are shown in Table 4 . The most volatile SCFA C2 and C3 showed a loss of, respectively, 2 0-30 and 15-25% during vacuum distillation, whereas the loss of the higher SCFA C4-C 6 amounted to only 0 -10%. Of course, these losses are accounted for when vacuum-distilled standards are used. DISCUSSION Many pitfalls have been found in the gas chromato graphic analysis of SCFA (23, 24) such as peak tailing due to adsorption, ghost peaks after repeated injec tions, double peak formation, azeotrope formation, or dimerization and loss by evaporation during prechro matographic manipulations. Van Eenaeme et al. (22) stated that the injection area which includes the injec tor, the column plugs, and the column top might be the principle cause of ghosting. The results in the present paper show that this also holds for the phenomena of peak tailing, peak broadening, and double peak forma tion. All these disturbances can be prevented by using formic acid in the injected sample and by using the technique of injection against the hot glass wall of an empty liner or by using injection between glass balls in a glass liner, the liner acting as a precolumn. Injec tion of the sample against hot glass appears to be very important for obtaining sharp peaks. Broad unresolved peaks were seen after injection in the gas phase of an empty liner. This might be explained by a temperature difference. The glass wall of the liner and the glass balls have about the same temperature as the injector (200°C), whereas the temperature in the gas phase of the liner is surely lower, mainly due to cooling by the N2 carrier gas stream through the liner. Injection in the gas phase might therefore result in a slower evapo ration of the sample and as a consequence of that in peak broadening.
With the technique described in the present study, fecal samples can be analyzed by GC without any pre treatment, The use of a precolumn protects the GC column against serious contamination with nonvolatile fecal material. The same gas chromatographic column is now in use for about 3 years for fecal SCFA. Despite a brown coloring of the first part of the column after some 10,000 injections of fecal samples, the retention times of the SCFA remained stable and no deteriora tion of the column was observed, again stressing the fact that the injection technique is more important for a good separation than the condition of the column. The use of about 10% formic acid in the injection sample is completely safe as was also shown by Coch rane (23), No corrosion of the metal parts of the gas chromatograph was observed, not even after 10 years.
In the previous literature about GC analysis of SCFA in aqueous solution, it was very common to add phos phoric acid to the glass wool and/or to the sample (21, 23-25). In the present study, we used dichlorodimethylsilane-treated glass wool in the liner. However, differ ent forms of glass wool (untreated, phosphoric acidtreated, and silanized) all gave the same results when injecting 9% formic acid test samples (data not shown), eliminating any influence of the glass wool on the SCFA separation in our setting, As previously reported (21-23), the use of formic acid as injection solvent is essen tial to prevent the adsorption of SCFA in the column, thereby eliminating peak tailing and ghosting. Another advantage of the use of formic acid in the sample is the high stability of the SCFA-end solutions, this in contrast to, e.g., phosphoric acid-end solutions, the lat ter resulting in a substantial reduction of SCFA within 30 min at room temperature, due probably to micellar separation (21) . Compared with the volatile formic acid, use of the nonvolatile phosphoric acid will also result in a faster contamination of the injection area, resulting in peak broadening.
In the past, direct injection of urine onto the GC column was used to measure the SCFA in urine (26) . No recovery and precision were determined in that study. The life span of the column was very shortened, due to contamination of nonvolatile compounds onto the column. The present method of direct injection in a glass precolumn may also be used for measuring SCFA in other biological fluids, e.g. in urine.
The fecal SCFA concentrations in normal healthy subjects found in this study were similar to those found by other groups (6, 13, 18, 20, 27-29 ) but were about twice as high as those found by Scheppach et al. (19) .
